We are live on
!
Find out more
GFM
GF Fund Management Portfolio holdings
AUM
$5.98B
1-Year Est. Return
80.99%
This Fund
S&P 500
This Quarter
Est. Return
+7.58%
1 Year Est. Return
+80.99%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$4.62B
AUM Growth
–
Cap. Flow
+$4.56B
Cap. Flow
% of AUM
98.7%
Top 10 Holdings %
Top 10 Hldgs %
48.03%
Holding
637
New
637
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$400M |
| 2 |
Apple
AAPL
|
+$352M |
| 3 |
Microsoft
MSFT
|
+$326M |
| 4 |
Amazon
AMZN
|
+$218M |
| 5 |
Meta Platforms (Facebook)
META
|
+$195M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 45.41% |
| 2 | Consumer Discretionary | 17.29% |
| 3 | Communication Services | 14.35% |
| 4 | Healthcare | 6.6% |
| 5 | Consumer Staples | 4.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
Pentair
PNR
$10.6B
| $335K | 0.01% |
+3,333
| New | +$342K |
|
252
Essex Property Trust
ESS
$19.1B
| $333K | 0.01% |
+1,167
| New | +$345K |
|
253
United Therapeutics
UTHR
$26.1B
| $331K | 0.01% |
+937
| New | +$344K |
|
254
Mid-America Apartment Communities
MAA
$16B
| $328K | 0.01% |
+2,124
| New | +$332K |
|
255
Sanofi
SNY
$107B
| $305K | 0.01% |
+6,322
| New | +$321K |
|
256
Summit Therapeutics
SMMT
$10.2B
| $302K | 0.01% |
+16,905
| New | +$328K |
|
257
Tyler Technologies
TYL
$13.7B
| $299K | 0.01% |
+518
| New | +$313K |
|
258
Neurocrine Biosciences
NBIX
$18.2B
| $290K | 0.01% |
+2,126
| New | +$263K |
|
259
Kimco Realty
KIM
$17.5B
| $287K | 0.01% |
+12,250
| New | +$297K |
|
260
Par Pacific Holdings
PARR
$4.17B
| $286K | 0.01% |
+17,464
| New | +$295K |
|
261
Bio-Techne
TECH
$11.2B
| $283K | 0.01% |
+3,929
| New | +$289K |
|
262
Alexandria Real Estate Equities
ARE
$9.37B
| $279K | 0.01% |
+2,861
| New | +$314K |
|
263
Sun Communities
SUI
$15.8B
| $279K | 0.01% |
+2,265
| New | +$290K |
|
264
Astera Labs
ALAB
$42.8B
| $265K | 0.01% |
+2,000
| New | +$188K |
|
265
BioMarin Pharmaceuticals
BMRN
$11.9B
| $263K | 0.01% |
+4,002
| New | +$268K |
|
266
Insmed
INSM
$22.4B
| $259K | 0.01% |
+3,756
| New | +$271K |
|
267
Healthpeak Properties
DOC
$15.5B
| $258K | 0.01% |
+12,707
| New | +$275K |
|
|
VTLE
268
DELISTED
Vital Energy
VTLE
| $257K | 0.01% |
+8,307
| New | +$246K |
|
269
Universal Health Services
UHS
$10.2B
| $254K | 0.01% |
+1,416
| New | +$288K |
|
270
IBM
IBM
$213B
| $248K | 0.01% |
+1,129
| New | +$251K |
|
271
UDR
UDR
$12.8B
| $247K | 0.01% |
+5,694
| New | +$252K |
|
272
Sarepta Therapeutics
SRPT
$1.64B
| $244K | 0.01% |
+2,006
| New | +$246K |
|
273
Gaming and Leisure Properties
GLPI
$13B
| $240K | 0.01% |
+4,986
| New | +$250K |
|
274
Royalty Pharma
RPRX
$26.2B
| $238K | 0.01% |
+9,329
| New | +$247K |
|
275
BioNTech
BNTX
$23.5B
| $235K | 0.01% |
+2,061
| New | +$235K |
|
Similar funds
CM
BP
AAM
CAG
WHRC
RCG
AL
CGPCS
GF Fund Management's Q4 2024 Portfolio in Review
Q4 2024 is the first quarter with a 13F filing on record for GF Fund Management, which disclosed 637 positions worth $4.62B. Its ten largest holdings account for 48% of the portfolio.
Its largest position is NVIDIA: 2,904,119 shares worth $390M.
By sector, the portfolio is most concentrated in Technology at 45% of assets, followed by Consumer Discretionary and Communication Services.
- GF Fund Management's largest Q4 2024 buy was NVIDIA: 2,904,119 shares worth $390M.
- GF Fund Management's ten largest holdings make up 48% of its $4.62B portfolio in Q4 2024.
- GF Fund Management disclosed 637 positions in Q4 2024, its first 13F filing on record.
Based on GF Fund Management's 13F filing for Q4 2024, filed 19 Feb 2025.